Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 30 most recent Form 4 transactions.
| MEXER◷◆ |
| 4,500 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Jun 12 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 4,500 | $50.00 | $225K | -9.8% | Open the original filing on SEC.gov |
| Jun 12 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,500 | $21.38 | $96.2K | +10.8% | Open the original filing on SEC.gov |
| May 19 | TVTX | Travere Therapeutics, Inc. | AGRANT◆ | 12,000 | — | — | — | Open the original filing on SEC.gov |
| May 19 | TVTX | Travere Therapeutics, Inc. | AGRANT | 4,000 | — | — | +10.7% | Open the original filing on SEC.gov |
| May 15 | NRIX | Nurix Therapeutics, Inc. | AGRANT◆ | 31,250 | — | — | — | Open the original filing on SEC.gov |
| May 5 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,500 | — | — | — | Open the original filing on SEC.gov |
| May 5 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 4,500 | $46.65 | $209.9K | -10.7% | Open the original filing on SEC.gov |
| May 5 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,500 | $18.27 | $82.2K | +12.0% | Open the original filing on SEC.gov |
| May 1 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 9,750 | — | — | — | Open the original filing on SEC.gov |
| May 1 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 9,750 | $44.22 | $431.1K | -20.6% | Open the original filing on SEC.gov |
| May 1 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 9,750 | $6.82 | $66.5K | +26.0% | Open the original filing on SEC.gov |
| Apr 24 | NTRA | Natera, Inc. | AGRANT | 83 | — | — | +0.4% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 6,750 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 9,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 8,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 6,750 | $42.12 | $284.3K | -15.3% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 26,000 | $41.07 | $1.1M | -37.0% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 6,750 | $17.11 | $115.5K | +10.6% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,500 | $21.38 | $96.2K | +7.6% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,500 | $18.27 | $82.2K | +8.3% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 9,000 | $15.43 | $138.9K | +19.8% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 8,000 | $17.94 | $143.5K | +21.3% | Open the original filing on SEC.gov |
| Apr 6 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 6 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 10,000 | $33.00 | $330K | -21.1% | Open the original filing on SEC.gov |
| Apr 6 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 10,000 | $26.52 | $265.2K | +26.7% | Open the original filing on SEC.gov |